Correlation Between Kandi Technologies and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kandi Technologies and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kandi Technologies and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kandi Technologies Group and Lipocine, you can compare the effects of market volatilities on Kandi Technologies and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kandi Technologies with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kandi Technologies and Lipocine.

Diversification Opportunities for Kandi Technologies and Lipocine

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kandi and Lipocine is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Kandi Technologies Group and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Kandi Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kandi Technologies Group are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Kandi Technologies i.e., Kandi Technologies and Lipocine go up and down completely randomly.

Pair Corralation between Kandi Technologies and Lipocine

Given the investment horizon of 90 days Kandi Technologies Group is expected to under-perform the Lipocine. But the stock apears to be less risky and, when comparing its historical volatility, Kandi Technologies Group is 1.17 times less risky than Lipocine. The stock trades about -0.1 of its potential returns per unit of risk. The Lipocine is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  577.00  in Lipocine on August 26, 2024 and sell it today you would lose (62.00) from holding Lipocine or give up 10.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kandi Technologies Group  vs.  Lipocine

 Performance 
       Timeline  
Kandi Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kandi Technologies Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Lipocine 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Kandi Technologies and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kandi Technologies and Lipocine

The main advantage of trading using opposite Kandi Technologies and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kandi Technologies position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind Kandi Technologies Group and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios